Lyse Norian

9PUBLICATIONS
25CO-AUTHORS
Food properties (incl. characteristics and health benefits)Molecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 16, 2024
An Exogenous Ketone Ester Slows Tumor Progression in Murine Breast and Renal Cancer Models.

Henry Nnaemeka Ogbonna, Zachary Roberts, Nicholas Godwin

|Apr 23, 2021
Comments on "Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns".

Andrew Brane, Michael Behring, Karina I Halilova

|Jan 11, 2021
Obesity diminishes response to PD-1-based immunotherapies in renal cancer.

Shannon K Boi, Rachael M Orlandella, Justin Tyler Gibson

|Dec 16, 2020
Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma.

Brandon M Roane, Selene Meza-Perez, Ashwini A Katre

|Oct 10, 2020
The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer.

Rachael M Orlandella, William J Turbitt, Justin T Gibson

Pageof 2